Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7XFT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,543
Award facts
- Contract value 100% obligated
- $37,542.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $37,542.84 delivery order to Amerisourcebergen Drug Corp on March 24, 2026, for Dupixent 300 mg/2 mL syringes under firm fixed-price terms.
The order is issued under the DLA Troop Support Medical IDC SPE2DX, a global pharmaceutical supply vehicle valued up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is March 25, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F7XFT?
SPE2DR26F7XFT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 24, 2026.
How much is contract SPE2DR26F7XFT worth?
The government has obligated $37,543 on SPE2DR26F7XFT.
Is contract SPE2DR26F7XFT an order under another contract?
Yes. SPE2DR26F7XFT is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7XFT competed?
The extent of competition for SPE2DR26F7XFT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award